Showing 1 – 3 of 3
Relevance | Newest | Oldest |
  • Use of Recommended Neurodiagnostic Evaluation Among Patients With Drug-Resistant Epilepsy

    Abstract Full Text
    ÁñÁ«ÊÓƵ Neurol. 2024; 81(5):499-506. 10.1001/jamaneurol.2024.0551

    This cross-sectional study examines the use of neurodiagnostic testing among patients with drug-resistant epilepsy.

  • Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods

    Abstract Full Text
    open access
    ÁñÁ«ÊÓƵ Netw Open. 2023; 6(3):e232598. 10.1001/jamanetworkopen.2023.2598

    This case control study evaluates the estimated vaccine effectiveness associated with 2, 3, or 4 doses of COVID-19 mRNA vaccination for protection against emergency department or urgent care encounters and against hospitalization among immunocompetent adults during a periods of Omicron BA.4 and BA.5 sublineage-predominant circulation.

  • Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States

    Abstract Full Text
    open access is active quiz
    ÁñÁ«ÊÓƵ Netw Open. 2022; 5(9):e2233273. 10.1001/jamanetworkopen.2022.33273

    This case-control study evaluates the estimated effectiveness of mRNA vaccination against medically attended COVID-19 among pregnant people during Delta and Omicron predominance in the United States.